Recent events
2026-02-01
Transactions
PRIMARY
In February 2026, Crescendo sold 7.6 million shares in HPSP at KRW 41,800 per share for KRW 317.7 billion, retaining a 20.11% minority stake
2026-01-09
Transactions
PRIMARY
Crescendo Equity Partners' most recent investment was in Medipost on January 9, 2026
2026-01-07
Other facts
PRIMARY
Crescendo completed a 300 billion won block deal of HPSP shares in January 2026 to repay acquisition financing
2026-01-07
Other facts
PRIMARY
In January 2026, Crescendo completed a 300 billion won after-hours block deal of HPSP shares, attracting strong interest from overseas institutions with demand exceeding 2 trillion won
2026-01-01
Transactions
PRIMARY
Crescendo Equity Partners has made 37 investments and 13 exits as of 2026
2025-12-03
Transactions
PRIMARY
Crescendo Equity Partners is seeking $1.25 billion for its latest flagship fund as of December 2025
2025-06-15
Other facts
SECONDARY
The absence of SEC enforcement actions, FINRA disciplinary records, and direct federal contracts for Crescendo Equity Partners is confirmed at PRIMARY confidence through publicly indexed enforcement databases and…
2025-06-15
Transactions
SECONDARY
The investigative gap preventing verification of the Thiel sponsorship claim is not absence of public records but failure to retrieve already-identified primary sources: SEC Form D Item 3 'Related Persons' disclosures…
2025-06-15
Transactions
SECONDARY
SEC Form D Item 3 'Related Persons' disclosures for Crescendo Equity Partners represent the most direct pathway to resolving FEC contribution questions, as these filings contain the individual names and affiliations…
2025-06-15
Transactions
SECONDARY
Korean beneficial ownership disclosure requirements under Article 147-2 of the Financial Investment Services and Capital Markets Act create mandatory English-language reporting for US persons holding >5% stakes in…
2025-06-15
Other facts
SECONDARY
Korean FSS DART beneficial ownership disclosure requirements create a mandatory 5-business-day reporting window for any >5% stake acquisition, making Crescendo's claimed 39.42% HPSP position subject to real-time…
2025-06-15
Transactions
SECONDARY
The investigative materiality of Korean FSS disclosures exceeds US enforcement records because they provide direct access to beneficial ownership structures that would trigger CFIUS mandatory filing requirements under…
2025-06-15
Other facts
SECONDARY
Form D filing sequence analysis represents the most direct method for resolving whether Crescendo operated multiple fund vehicles or conducted sequential closings of a single fund during the 2020-2022 period
2025-06-15
Transactions
SECONDARY
SEC Form D Item 9 disclosures for Crescendo Equity Partners represent the most direct method for resolving AUM claims, as these mandatory filings contain exact 'Total Offering Amount' and 'Amount Sold' figures that…
2025-06-15
Other facts
SECONDARY
The aggregation methodology for Crescendo's six Form D filings requires analysis of Item 6 'Type of Filing' to determine whether submissions represent separate fund vehicles (requiring addition) or sequential closings…
2025-06-15
Transactions
SECONDARY
Form D Item 9 'Amount Sold' figures across Crescendo's 16-month filing period would provide month-by-month fundraising velocity data, allowing assessment of whether the $1.5B claim represents peak AUM or sustained…
2025-06-15
Transactions
SECONDARY
The methodological pathway to resolve FEC contribution questions for Crescendo Equity Partners is documented but unexecuted: SEC Form D Item 3 disclosures contain the individual names required for FEC database searches…
2025-06-15
Transactions
SECONDARY
The investigative priority for Crescendo Equity Partners should focus on retrieving SEC CIK identifier and Form D Item 3 disclosures rather than conducting speculative name-based searches, as these primary sources…
2025-06-15
Other facts
SECONDARY
The US-China Economic and Security Review Commission, which reports annually to Congress on strategic technology dependencies, represents an unsearched quasi-parliamentary source that may reference Korean semiconductor…
2025-06-15
Other facts
SECONDARY
Congressional commission reports represent a distinct category of quasi-parliamentary documentation that may contain supply chain analysis without triggering the same ownership disclosure requirements as formal CFIUS…
2025-06-15
Other facts
SECONDARY
The methodological resolution of Thiel sponsorship verification requires a documented but unexecuted two-step process: SEC Form D Item 3 retrieval followed by targeted FEC employer-based searches using identified…
2025-06-15
Other facts
SECONDARY
The absence of Crescendo Equity Partners from English-language parliamentary records is a jurisdictional artifact rather than evidence of non-relevance—the appropriate legislative repository is Korea's National…
2025-06-15
Other facts
SECONDARY
The specific SEC enforcement action claim can be verified as PRIMARY confidence: SEC enforcement releases and litigation releases are publicly indexed, and absence of 'Crescendo Equity Partners' from these databases…
2025-06-15
Transactions
SECONDARY
The inferential claim's framing of entity ambiguity is accurate regarding global corporate namespace but misleading regarding investigative tractability—sufficient identifiers exist in available fact base to…
2025-06-15
Transactions
SECONDARY
Korean FSS DART beneficial ownership disclosures represent the highest-priority uninvestigated primary source for resolving Crescendo Equity Partners' portfolio claims and beneficial ownership structures
+56 earlier events on the chart
GOBLIN HOUSE
[ Enter Database → ]